Based on the TotiCyte platform, T-PRP is the world’s first entirely cell-free, concentrated platelet-factor-rich plasma.
100% cell free – 1 in 4 interarticular injections using other PRP systems will result in a flare. A flare is inflammation in the joint, which may result in significant pain for up to 48 hours.
T-PRP is free of any cells or cellular debris. This greatly reduces the risk of a flare. In a recent clinical study 20 dogs were treated using T-PRP and none developed any kind of pain or inflammation; as yet no flares have been reported using T-PRP.
Predictable concentration level – TotiCyte holds all platelets in a blood sample in an inactivated state until the plasma has been reduced to the desired volume. This means that the platelet factors are not released and lost during processing.
As a result, T-PRP can be consistently concentrated to the required level – every time.
Variable volumes – T-PRP can be concentrated to any volume without any loss to the platelet factors. This means that highly concentrated PRP can be injected into the smallest of joints.
- Mix equal volumes of blood and TotiCyte and rest for 30 minutes
- Dispose of the red cell fraction
- Centrifuge to pellet the white cell fraction and platelets
- Remove excess plasma
- Re-suspend the pellet and activate the platelets with CaCl2
- Centrifuge again to pellet the cells
- Extract the platelet-factor-rich-plasma and filter
For purchasing information, please contact us on 01444 873950 or via email: email@example.com
TotiCyte is beneficial in most procedures that require the removal of red cells and the isolation of other blood components from whole blood.
Currently we provide TotiCyte protocols for:
For all other applications, please contact us on 01444873950 for more information.